Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,799.50

Bid: 1,796.00

Ask: 1,796.50

Change: 19.00 (1.07%)

Spread: 0.50 (0.028%)

Open: 1,784.00

High: 1,799.50

Low: 1,780.00

Prev. Close: 1,780.50

Last checked at -

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Mon, 27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

SocGen raises Rolls-Royce price target to 148 pence - 'hold'

----------

Bank of America raises Rolls-Royce to 'buy' (underperform) - price target 175 (97) pence

----------

Jefferies raises Rolls-Royce price target to 170 (125) pence - 'buy'

----------

Jefferies raises BAE Systems price target to 1,060 (1,000) pence - 'buy'

----------

SocGen raises BAE Systems price target to 1,086 pence - 'buy'

----------

Bank of America raises International Consolidated Airlines price target to 240 (200) pence - 'buy'

----------

Barclays raises International Consolidated Airlines price target to 165 (160) pence - 'equal weight'

----------

Bernstein raises International Consolidated Airlines price target to 190 (180) pence - 'outperform'

----------

Goldman Sachs raises BP price target to 740 (690) pence - 'conviction buy list'

----------

Goldman Sachs raises Shell to 'buy' (neutral) - price target 40 (35) EUR

----------

Goldman Sachs raises Vodafone price target to 130 (120) pence - 'buy'

----------

Jefferies cuts Mondi price target to 1,710 (1,730) pence - 'buy'

----------

Jefferies cuts British American Tobacco price target to 4,100 (4,700) pence - 'buy'

----------

Jefferies cuts Imperial Brands price target to 1,993 (2,007) pence - 'hold'

----------

HSBC raises Rightmove to 'hold' - price target 530 pence

----------

Barclays cuts Anglo American price target to 2,900 (3,250) pence - 'equal weight'

----------

Goldman Sachs reinitiates GSK with 'buy' - price target 2,000 pence

----------

Citigroup cuts Hargreaves Lansdown to 'sell' - price target 730 pence

----------

JPMorgan raises Lloyds price target to 61 (58) pence - 'neutral'

----------

JPMorgan raises NatWest price target to 340 (330) pence - 'neutral'

----------

JPMorgan raises Barclays price target to 240 (230) pence - 'overweight'

----------

Deutsche Bank raises Standard Chartered price target to 890 (800) pence - 'hold'

----------

Barclays raises Prudential price target to 1,750 (1,518) pence - 'overweight'

----------

FTSE 250

----------

Citigroup cuts Quilter to 'sell' - price target 75 pence

----------

Berenberg raises Hikma Pharmaceutical target to 1,740 (1,440) pence - 'hold'

----------

Barclays raises Jupiter Fund price target to 130 (120) pence - 'equal weight'

----------

Peel Hunt cuts Howden Joinery Group to 'add' (buy) - price target 770 (700) pence

----------

Deutsche Bank raises Trainline to 'buy' (hold) - price target 287 (350) pence

----------

Jefferies raises Senior price target to 195 (180) pence - 'buy'

----------

SMALL CAP

----------

Berenberg cuts Resolute Mining price target to 24 (25) pence - 'buy'

----------

Jefferies raises Conduit Holdings price target to 650 (620) pence - 'buy'

----------

More News

13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Login to your account

Quickpicks are a member only feature

Login to your account